Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Successful Combination of Neuraxial and Regional Anesthesia in a Child With Advanced Spinal Muscular Atrophy Type 1 Receiving Maintenance Nusinersen Therapy: A Case Report. | A A Pract | 2020 | 32784322 | PubTator, text mining | PubMed |
| Neuromuscular disorders in pregnancy. | Handb Clin Neurol | 2020 | 32768089 | PubTator, text mining | PubMed |
| The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe. | Int J Environ Res Public Health | 2020 | 32764338 | PubTator, text mining | PubMed |
| European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy. | Eur J Paediatr Neurol | 2020 | 32763124 | PubTator, text mining | PubMed |
| CRISPR/Cas: a potential gene-editing tool in the nervous system. | Cell Regen | 2020 | 32761306 | PubTator, text mining | PubMed |
| Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease. | Front Genet | 2020 | 32760425 | PubTator, text mining | PubMed |
| The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment. | J Pers Med | 2020 | 32751151 | PubTator, text mining | PubMed |
| The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. | Acta Neuropathol | 2020 | 32748079 | PubTator, text mining | PubMed |
| Muscle MRI in two SMA patients on nusinersen treatment: A two years follow-up. | J Neurol Sci | 2020 | 32745721 | PubTator, text mining | PubMed |
| Intelligent Ratio: A New Method for Carrier and Newborn Screening in Spinal Muscular Atrophy. | Genet Test Mol Biomarkers | 2020 | 32721240 | PubTator, text mining | PubMed |
| Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders. | Genet Test Mol Biomarkers | 2020 | 32721234 | PubTator, text mining | PubMed |
| Diagnostic Testing for Patients with Spinal Muscular Atrophy. | Clin Lab Med | 2020 | 32718505 | PubTator, text mining | PubMed |
| Comment on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al. | J Cachexia Sarcopenia Muscle | 2020 | 32716121 | PubTator, text mining | PubMed |
| Combination molecular therapies for type 1 spinal muscular atrophy. | Muscle Nerve | 2020 | 32710634 | PubTator, text mining | PubMed |
| Author response: Discrepancy in redetermination of SMN2 copy numbers in children with SMA. | Neurology | 2020 | 32690781 | PubTator, text mining | PubMed |
| Reader response: Discrepancy in redetermination of SMN2 copy numbers in children with SMA. | Neurology | 2020 | 32690780 | PubTator, text mining | PubMed |
| Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy. | Theranostics | 2020 | 32685027 | PubTator, text mining | PubMed |
| A consensus statement on spinal muscular atrophy management in Saudi Arabia in the context of COVID-19. | Neurosciences (Riyadh) | 2020 | 32683408 | PubTator, text mining | PubMed |
| Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3. | NMR Biomed | 2020 | 32681555 | PubTator, text mining | PubMed |
| New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. | J Clin Med | 2020 | 32668756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=78